Feline Sarcoma Oncogene (FES) Peptide
FES
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all FES products
- FES (Feline Sarcoma Oncogene (FES))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ARDSAQAKRK YQEASKDKDR DKAKDKYVRS LWKLFAHHNR YVLGVRAAQL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FES antibody,
Alternative Names: FES control peptide, FES antibody Blocking Peptide, Anti-FES Blocking Peptide, Feline Sarcoma Oncogene Blocking Peptide, FPS Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- FES (Feline Sarcoma Oncogene (FES))
- Synonyms
- FPS Peptide, RGD1564385 Peptide, AI586313 Peptide, BB137047 Peptide, c-fes Peptide, FES Peptide, c-fps Peptide, FES proto-oncogene, tyrosine kinase Peptide, feline sarcoma oncogene Peptide, FES Peptide, Fes Peptide, fes Peptide
- Background
- FES is the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. FES has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis.
- Molecular Weight
- 93 kDa
-
You are here:
